"Overall vacancy rose to 26.4%, an increase of 610 basis points year over year, driven in part by the addition of 2.5 million square feet of new life sciences space."

"Overall vacancy declined 160 basis points (bps) year over year to 37.6% from 39.2%, signaling a slight positive shift in the market."

"Overall vacancy declined 320 basis points (bps) year over year to 23.8% from 27.0% in Q2 2025, while direct vacancy, sublease vacancy and total available space also decreased over the same period."

"Overall vacancy increased by 70 basis points (bps) year over year to 32.5% from 31.8% in Q2 2025, reflecting continued elevated availability in the market."

"Overall vacancy increased to 24.4%, up 890 basis points year over year from 15.5%, primarily due to the addition of several large availabilities to the market. Sublease vacancy also rose sharply, increasing from 1.6% in Q2 2025 to 3.0% in Q2 2026."

"Overall vacancy increased by 260 basis points year over year to 7.3% from 4.7%. However, Philadelphia continues to post one of the lowest vacancy rates among the nation's leading life sciences markets."

"Overall vacancy decreased by 160 basis points (bps) year over year to 23.1% from 24.7% in Q2 2025. Total available space also declined by 1.3 million square feet (msf) to 3.3 msf, reflecting continued market absorption."

"Overall vacancy remained essentially unchanged year over year at 28.1%, down 10 basis points (bps) from 28.2% in Q2 2025, while available space increased from 8.9 million square feet (msf) to 9.4 msf over the same period."

"Overall vacancy increased by 310 basis points (bps) to 26.2% from 23.1% in Q2 2025, driven in part by the delivery of more than 500,000 square feet (sf) of new life sciences space at Avia Labs and 1699 Bayshore Highway."

"Overall vacancy increased by 540 basis points (bps) year over year to 19.0% from 13.6% in Q2 2025, partially driven by the addition of life sciences space outpacing demand."